31MAR

Welcome To Mediterr J Med Res

Manuscripts are accepted for consideration with understanding that they are represent original material and they are not being considered for publication elsewhere. The editors welcome the submission of relevant articles for editorial consideration. Manuscripts and all scientific and professional data should be addressed to Editor-in-Cheif (abdulgbaj1@hotmail.com / Fmosherif@yahoo.com).

Mediterranean Journal of Medical Research
https://mrj.org.ly/

Mediterranean Journal of Medical Research

 

Manuscripts should be addressed to Editor-in-Chief: abdulgbaj1@hotmail.com / Fmosherif@yahoo.com

 

 

Google Scholar     معامل التأثير العربي     

 

 Directory of Online Libyan Journals  

 

 

 

Publishing timeline

  • 15 days: Time to first decision  
  • 45 days: Review time
  • 60 days: Submission to acceptance
  • 15 days: Acceptance to publication

Acceptance rate:  67.02%

Volume 3, Issue 2, 2026 June

3(2), 2026 June

Review

Highlight https://doi.org/10.5281/zenodo.19373711
CRISPR-Cas9-based functional analysis of PARP inhibitor response in BRCA-mutated breast cancer and its implications for precision pharmacogenomics Fathima, Nousheen, Karunakar Hegde BRCA1/BRCA2 mutations, PARP inhibitor resistance, precision therapy, synthetic lethality

ReviewMolecular biology
logo

Editor-in-chief
Prof. Abdul M Gbaj


Periodicity:
Quarterly

Published by:
Libyan Association for Pharmacists


  • Most Viewed

  • Most downloaded

Mediterr J Med Res

Share this page
Page Sections